| Three-dimensional cell cultures in drug discovery and development Y Fang, RM Eglen Slas discovery: Advancing Life Sciences R&D 22 (5), 456-472, 2017 | 960 | 2017 |
| Muscarinic receptor subtypes and smooth muscle function RM Eglen, SS Hegde, N Watson Pharmacological reviews 48 (4), 531-565, 1996 | 789 | 1996 |
| Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development J Wess, RM Eglen, D Gautam Nature reviews Drug discovery 6 (9), 721-733, 2007 | 755 | 2007 |
| Structure and function of a novel voltage-gated, tetrodotoxin-resistant sodium channel specific to sensory neurons L Sangameswaran, SG Delgado, LM Fish, BD Koch, LB Jakeman, ... Journal of Biological Chemistry 271 (11), 5953-5956, 1996 | 504 | 1996 |
| Distribution of the tetrodotoxin-resistant sodium channel PN3 in rat sensory neurons in normal and neuropathic conditions SD Novakovic, E Tzoumaka, JG McGivern, M Haraguchi, ... Journal of Neuroscience 18 (6), 2174-2187, 1998 | 503 | 1998 |
| Assessment of the role of α2‐adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice JC Hunter, DJ Fontana, LR Hedley, JR Jasper, R Lewis, RE Link, ... British journal of pharmacology 122 (7), 1339-1344, 1997 | 446 | 1997 |
| Muscarinic receptor subtypes in neuronal and non‐neuronal cholinergic function RM Eglen Autonomic and Autacoid Pharmacology 26 (3), 219-233, 2006 | 426 | 2006 |
| The pharmacology and distribution of human 5‐hydroxytryptamine2B (5‐HT2b) receptor gene products: comparison with 5‐HT2a and 5‐HT2c receptors DW Bonhaus, C Bach, A DeSouza, FHR Salazar, BD Matsuoka, P Zuppan, ... British journal of pharmacology 115 (4), 622-628, 1995 | 414 | 1995 |
| A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/SNS and NaN/SNS2, in rat models of chronic pain F Porreca, J Lai, DI Bian, S Wegert, MH Ossipov, RM Eglen, L Kassotakis, ... Proceedings of the National Academy of Sciences 96 (14), 7640-7644, 1999 | 401 | 1999 |
| Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo SS Hegde, A Choppin, D Bonhaus, S Briaud, M Loeb, TM Moy, D Loury, ... British journal of pharmacology 120 (8), 1409-1418, 1997 | 401 | 1997 |
| The use of AlphaScreen technology in HTS: current status RM Eglen, T Reisine, P Roby, N Rouleau, C Illy, R Bossé, M Bielefeld Current chemical genomics 1, 2, 2008 | 340 | 2008 |
| Muscarinic acetylcholine receptor subtypes in smooth muscle RM Eglen, H Reddy, N Watson, RAJ Challiss Trends in pharmacological sciences 15 (4), 114-119, 1994 | 327 | 1994 |
| A novel tetrodotoxin-sensitive, voltage-gated sodium channel expressed in rat and human dorsal root ganglia L Sangameswaran, LM Fish, BD Koch, DK Rabert, SG Delgado, M Ilnicka, ... Journal of Biological Chemistry 272 (23), 14805-14809, 1997 | 317 | 1997 |
| RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist DW Bonhaus, KK Weinhardt, M Taylor, A DeSouza, PM McNeeley, ... Neuropharmacology 36 (4-5), 621-629, 1997 | 308 | 1997 |
| Central 5-HT4 receptors RM Eglen, EHF Wong, A Dumuis, J Bockaert Trends in Pharmacological Sciences 16 (11), 391-398, 1995 | 307 | 1995 |
| The role of IP prostanoid receptors in inflammatory pain KR Bley, JC Hunter, RM Eglen, JAM Smith Trends in pharmacological sciences 19 (4), 141-147, 1998 | 302 | 1998 |
| Seeing through a glass darkly': casting light on imidazolineI'sites RM Eglen, AL Hudson, DA Kendall, DJ Nutt, NG Morgan, VG Wilson, ... Trends in pharmacological sciences 19 (9), 381-390, 1998 | 299 | 1998 |
| Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder SS Hegde, RM Eglen Life sciences 64 (6-7), 419-428, 1999 | 298 | 1999 |
| Virtual screening for bioactive molecules RM Eglen, G Schneider, HJ Böhm Wiley-VCH. Weinheim, Alemania, 2000 | 286 | 2000 |
| Characterization and distribution of putative 5‐ht7 receptors in guinea‐pig brain ZP To, DW Bonhaus, RM Eglen, LB Jakeman British journal of pharmacology 115 (1), 107-116, 1995 | 286 | 1995 |
